Differentiation between perianastomotic inflammatory changes and local recurrence following neoadjuvant radiochemotherapy surgery for colorectal cancer using visual and semiquantitative analysis of PET-CT data

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 54, Issue 3, 2010, Pages 327-332

  Smeets, P ^a   Ham, H ^a   Ceelen, W ^a   Boterberg, T ^a   Verstraete, K ^a   Goethals, I ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Anastomosis, surgical; Colorectal neoplasms; Computed tomography; Fluorodeoxyglucose F18; Positron emission tomography

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IOHEXOL; IOMEPROL; DIAGNOSTIC AGENT; FLUORINE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ANASTOMOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; IMAGING; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; SENSITIVITY AND SPECIFICITY; ADJUVANT THERAPY; COLORECTAL TUMOR; MIDDLE AGED; RADIOGRAPHY; RETROSPECTIVE STUDY; SCINTISCANNING; TUMOR RECURRENCE;

AGED; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77958549706     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg 2006;93:1115-22.
2. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ Jr, Pemberton JH et al. Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 1992;174:27-32.
3. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev 2002;CD002200.
4. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002;324:813.
5. Figueredo A, Rumble RB, Maroun J, Earle CC, Cummings B, McLeod R et al.; Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003;3:26.
6. Desch CE, Benson AB 3rd, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL et al.; American Society of Clinical Oncology. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 2005;23:8512-9. Erratum in: J Clin Oncol 2006;24:1224.
7. Hustinx R. PET imaging in assessing gastrointestinal tumors. Radiol Clin North Am 2004;42:1123-39, ix.
8. Geus-Oei LF, Ruers TJ, Punt CJ, Leer JW, Corstens FH, Oyen WJ. FDG-PET in colorectal cancer. Cancer Imaging 2006,6.S71-S81.
9. Even-Sapir E, Parag Y, Lerman H, Gutman M, Levine C, Rabau M et al. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Radiology 2004;232:815-22.
10. 18F-fluorodeoxyglucose positron emission tomography contributes to the diagnosis and management of infections in patients with multiple myeloma: a study of 165 infectious episodes. J Clin Oncol 2005;23:7857-63.
11. Goshen E, Davidson T, Aderka D, Zwas ST. PET/CT detects abdominal wall and port site metastases of colorectal carcinoma. Br J Radiol 2006;79:572-7.
12. Votrubova J, Belohlavek O, Jaruskova M, Oliverius M, Lohynska R, Trskova K et al. The role of FDG-PET/CT in the detection of recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2006;33:779-84.
13. Thomson WH, Foy CJ, Longman RJ. The nature of local recurrence after colorectal cancer resection. Colorectal Dis 2008;10:69-74.
14. Flamen P. Positron emission tomography in colorectal cancer. Best Pract Res Clin Gastroenterol 2002;16:237-51.
15. Selvaggi F, Cuocolo A, Sciaudone G, Maurea S, Giuliani A, Mainolfi C. FGD-PET in the follow-up of recurrent colorectal cancer. Colorectal Dis 2003;5:496-500.
16. Cohade C, Osman M, Leal J, Wahl RL. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 2003;44:1797-803.
17. Delbeke D, Vitola JV, Sandler MP, Arildsen RC, Powers TA, Wright JK Jr et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 1997;38:1196-201.
18. Tatlidil R, Jadvar H, Bading JR, Conti PS. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology 2002;224:783-7.
19. Boellaard R, Krak N, Hoekstra O, Lammertsma A. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. J Nucl Med 2004;45:1519-27.
20. Krak N, Boellaard R, Hoekstra O, Twisk J, Hoekstra C, Lammertsma A. Effects of ROI definition and reconstuction method on quantitative outcome and applicability in a response monitoring trial. Eur J Nucl Med Mol Imaging 2005;32:294-301.
21. Westerterp M, Pruim J, Oyen W, Hoekstra O, Paans A, Visser E et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007;34:392-404.